論文

2025年

英文

  1. Imoto W, Imai T, Kawai R, Ihara Y, Nonomiya Y, Namikawa H, Yamada K, Yoshida H, Kaneko Y, Shintani A, Kakeya H. Incidence and Potential Risk Factors of Human Cytomegalovirus Infection in Patients with Severe and Critical Coronavirus disease 2019. J Infect Chemother. 2025 Jan31(1):102452.
    doi: 10.1016/j.jiac.2024.06.015.
  2. Nishiyama A, Nogimori T, Masuta Y, Matsuura T, Kase T, Kondo K, Ohfuji S, Nakagama Y, Kaku N, Nakagama S, Nitahara Y, Takahashi Y, Kakeya H, Kido Y, Fukushima W, Yamamoto T. Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination. Vaccines(Basel) 2025 Jan 28;13(2):140.
    doi:10.3390/vaccines13020140.PMID: 40006687
  3. Kasamatsu A, Ohfuji S, Suita A, Kondo K, Nakata H, Kita T, Deguchi A, Fujimoto M, Iba K, Sakamoto H, Iwasaka K, Sakamoto N, Sakamoto H, Yodoi Y, Kido Y, Nakagama Y, Konishi A, Mukai E, Matsumoto K, Matsuura T, Kase T, Kakeya H, Fukushima W, Hirota Y. Durability of antibody titers and associated factors after the booster dose of COVID-19 mRNA vaccination in Japanese SARS-CoV-2 infection-naive residents in geriatric intermediate care facilities. Geriatric Gerontol Int, 2025 Mar 15.
    doi: 10.1111/ggi.70028.
  4. Komiya K, Hagiwara A, Shindo Y, Takamatsu K, Nishimura N, Takechi Y, Ichihara E, Takazono T, Izumi S, Gotoh S, Sakao S, Izumo T, Yamamoto K, Yatera K, Kakeya H, Shibata Y, Tomii K, Sagara H, Sasaki Y, Hirai T, Yokoyama A, Mukae H, Ogura T. Influence of Educational Films on Antiviral Prescription for COVID-19: Insights from Web-Based Survey in Japan. Antibiotics(Basel) 2025 Mar 7;14(3):276.
    doi: 10.3390/antibiotics14030276.
  5. Kawamoto K, Imoto W, Kimura Y, Kakuno S, Shibata W, Myodo Y, Nishimura T, Ehara S, Fujii H, Mizobata Y, Shibata T, Kakeya H. Incidence and risk factors of COVID-19-associated pulmonary aspergillosis in severe cases: A single-center study from Japan. J Infect Chomoether 2025 Mar 7;31(4):102676.
    doi: 10.1016/j.jiac.2025.102676.
  6. Imoto W, Ihara Y, Bito T, Kawai R, Namikawa H, Shibata W, Kaneko Y, Shintani A, Kakeya H. Assessment of incidence and risk factors of COVID-19-associated candidemia using diagnosis procedure combination data. J Infect Chemother, 2025 Mar27.102689.
    https://doi.org/10.1016/j.jiac.2025.102689
  7. Namikawa H, Oinuma K , Kaneko Y, Kakeya H, Shuto T. Antimicrobial resistance in hypermucoviscous and non-hypermucoviscous Klebsiella pneumoniae: a systematic review and meta-analysis. Emerg Microbes Infect. 2025 Dec;14(1):2438657
    doi: 10.1080/22221751.2024.2438657. Epub 2024 Dec 16.
  8. Konishi A, Fukushima W, Matsuura T, Ohfuji S, Kase T, Kondo K, Matsumoto K, Suita A, Mukai E, Kasamatsu A, Kido Y, Nakagama Y, Nitahara Y, Kaneko Y, Kaneko A, Nakagami-Yamaguchi E, Kakeya H, Hirota Y. Adverse reactions following first three doses of the BNT162b2 mRNA COVID-19 vaccine: A prospective cohort study on relationships with individual characteristics and previous experience of adverse reactions. Hum Vaccin Immunother. 2025 Dec;21(1):2518646.
    doi: 10.1080/21645515.2025.2518646. Epub 2025 Jun 24.
  9. Ito Y, Takazono T, Namie H, Tashiro M, Kakeya H, Miyazaki Y, Mukae H, Mikamo H, Fukuda T, Shibuya K, Izumikawa K. Incidence of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis and Specialist Involvement in Its Diagnosis in Japan: A Nationwide Survey and Literature Review. Mycoses. 2025 Jun;68(6):e70077.
    doi: 10.1111/myc.70077.
  10. ItoY, Takazono T, Namie H, Tashiro M, Kakeya H, Miyazaki Y, Mukae H, Mikamo H, Fukuda T, Shibuya K, Izumikawa K. A nationwide epidemiological survey of coronavirus disease 2019-associated pulmonary aspergillosis in Japan. J Infect Chemother. 2025 Jul;31(7):102739. doi: 10.1016/j.jiac.2025.102739. Epub 2025 May 26.
  11. Ishihara R, Watanabe R, Yao A, Kuwamoto T, Katsushima M, Fukumoto K, Tanaka S, Kakutani Y, Shibata A, Yamada S, Fukushima W, Kakeya H, Shoji T, Emoto M, Shimono T, Hashimoto M. A Case of IgG4-Related Disease Potentially Triggered by COVID-19 Vaccination: Longitudinal Serum IgG4 Monitoring from Prevaccination. Mod Rheumatol Case Rep.: 10.1093/mrcr/rxaf039.
  12. Ueda T, Kakeya H, Yoshida K, Hisato A, Ukimura A, Ogawa T, Nakajima K, Iijima K, Nagao M, Tsuchido Y, Kawamura H, Shigemi A, Hotomi M, Kono M, Kasahara K, Imakita N, Kaneko Y, Niki M, Yamada K, Kakuno S, Miyazaki T, Sumiyoshi M, Murakami Y, Doi M, Yoshioka M, Miyazaki Y, Takesue Y. Pitt candidaemia score as an assessment tool for mortality in patients with candidaemia caused by Candida tropicalis and other Candida species: a multicentre study conducted in Japan. JAC Antimicrob Resist. 2025 May 20;7(3):dlaf078. doi: 10.1093/jacamr/dlaf078. eCollection 2025 Jun.
  13. Yasui Y, Yashui H, Yamaoto Y, Ishizuka T, Hatanaka K, Imoto W, Shibata W, Yamda K, Kakeya H. Prospective analysis of factors influencing inter-individual variation in through plasma voriconazole concentration in older patients – Impact of high α1-Acid glycoprotein levels. Biol Pham Bull 48, 1-12, 2025, 48, 694–705. doi: 10.1248/bpb.b25-00057.
  14. Kakuno S, Shibata W, Kawamoto K, Imoto W, Yamda K, Niki M, Kaneko Y, Umeyama T, Miyazaki Y, Kakeya H. Development of an In Vitro Electrical Impedance Model to Assess Cytotoxicity and Antifungal Efficacy of Aspergillus fumigatus. Med Mycol J. 66,105-112, 2025.
  15. Kakuno S, Imoto W, Yamada K, Ihara Y, Yamada K, Tanaka M, Kuwabara G, Sawa K, Terachi T, Mizutani T, Kitazato M, Yoshimura M, Yoshii N, Shintani A, Kakeya H. Impact of the COVID-19 pandemic on infectious disease treatment and infection control in Japan: A retrospective multicenter study. Heliyon 2025, accepted.

和文

  1. 掛屋 弘. 私を変えたあの一言. Infection Control, メディカ出版, 34:1, 2025.
  2. 掛屋 弘. 敗血症. 今日の治療指針, 医学書院, 東京, 2025, pp208-210
  3. 掛屋 弘. Candida auris. 感染症最新の治療2025-2027, 南江堂, 東京, 2025. pp278-280
  4. 掛屋 弘. 緑膿菌感染症. 呼吸器疾患最新の治療2025-2026, 南江堂, 東京, 2025. pp221-224
  5. 掛屋 弘. 深在性真菌症. 今日の診断指針 第９版, 医学書院, 東京, 2025, pp2285-2286
  6. 掛屋 弘. 肺炎診療ガイドライン改訂ポイントと抗菌薬適正使用. 大阪保険医雑誌. 3:35-43,2025
  7. 掛屋　弘, 柴多　渉, 井本和紀, 金子幸弘. COVID-19 患者におけるカンジダ血症の発症割合および転機への影響（日本医真菌学会）. 厚生労働行政推進調査事業費補助金（新興・再興感染症及び予防接種政策推進研究事業）新型コロナウイルス感染症による医学・医療・健康に与えた中長期的影響の調査研究－今後の保健・医療体制整備の観点から－
    （23HA2011）研究報告書. 15-18, 2025
  8. 仁木　誠, 掛屋　弘. 糸状菌の同定と薬剤感受性検査. 日本臨床検査医学会誌, 73:480-485, 2025.